218 related articles for article (PubMed ID: 31371628)
1. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
Chen L; Huang Y; Zhou L; Lian Y; Wang J; Chen D; Wei H; Huang M; Huang Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31371628
[No Abstract] [Full Text] [Related]
2. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma.
Mei J; Wang H; Wang R; Pan J; Liu C; Xu J
Biomed Res Int; 2020; 2020():5751939. PubMed ID: 32258128
[TBL] [Abstract][Full Text] [Related]
3. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
4. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients.
Ning G; Huang YL; Zhen LM; Xu WX; Jiao Q; Yang FJ; Wu LN; Zheng YY; Song J; Wang YS; Xie C; Peng L
Aging (Albany NY); 2018 Nov; 10(11):3450-3473. PubMed ID: 30481161
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
Zhuang L; Yang Z; Meng Z
Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
[TBL] [Abstract][Full Text] [Related]
7. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
Tian F; Xu J; Xue F; Guan E; Xu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
[TBL] [Abstract][Full Text] [Related]
9. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
11. Identification of CDC25C as a Potential Biomarker in Hepatocellular Carcinoma Using Bioinformatics Analysis.
Xun R; Lu H; Wang X
Technol Cancer Res Treat; 2020; 19():1533033820967474. PubMed ID: 33111630
[TBL] [Abstract][Full Text] [Related]
12. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.
Xu W; Wang X; Wu X; Yu S; Xiong J; Sang X; Zheng Y; Zhang Z
Aging (Albany NY); 2020 Aug; 12(16):16420-16436. PubMed ID: 32855364
[TBL] [Abstract][Full Text] [Related]
14. Systematic summarization of the expression profiles and prognostic roles of the dishevelled gene family in hepatocellular carcinoma.
Mei J; Yang X; Xia D; Zhou W; Gu D; Wang H; Liu C
Mol Genet Genomic Med; 2020 Sep; 8(9):e1384. PubMed ID: 32588988
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
16. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
Gao J; Jia WD
Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma.
Wang HJ; Wang L; Song SS; He XL; Pan HY; Hu ZM; Mou XZ
Cancer Biomark; 2018 Feb; 21(3):723-730. PubMed ID: 29278884
[TBL] [Abstract][Full Text] [Related]
18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
[TBL] [Abstract][Full Text] [Related]
20. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
